drugset / Trial / NCT01400945

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

NCT01400945

Phase 3 Completed 154 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate treatment in Gastroesophageal Reflux Disease (GERD) patients (aged 18\~75) with endoscopically proven GERD treated with AGSPT201 Tablet.

Timeline

Start
2009-12
Primary completion
2011-08
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject S-pantoprazole Unknown